Lettiere, Daniel J.
Pfizer (United States)
2 papers on CoChatORCID 0000-0002-3164-3290
Most cited papers
- Verified
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
Gonzales, A. J., Hook, K. E., Althaus, I. W., Ellis, P. A., Trachet, E., Delaney, A. M., Harvey, P. J., Ellis, T. A., Amato, D. M., Nelson, J. M., et al. (2008) · Molecular Cancer Therapeutics
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 226
- Verified
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., et al. (2022) · Journal of Medicinal Chemistry
Diabetes Treatment and ManagementReceptor Mechanisms and Signaling
Cited by 192
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free